January 30, 2023Open Access

Targeting m 6 A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

YTHDF1 impairs antitumour immunity via an m6A-p65-CXCL1/CXCR2 axis to promote CRC and serves as a therapeutic target in immune checkpoint blockade therapy.

Me gusta

Guardar

Ver artículo completo

Cite This Study

Bao et al. (Mon,) studied this question.

synapsesocial.com/papers/69dc803824e766dc313594dd https://doi.org/https://doi.org/10.1136/gutjnl-2022-328845

Me gusta

Guardar

Ver artículo completo